C4 Therapeutics Financial Overview
C4 Therapeutics's market cap is currently $219.03M. The company's EPS TTM is $-0.44; its P/E ratio is -1.23; C4 Therapeutics is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.29. See an overview of income statement, balance sheet, and cash flow financials.
